Small animal imaging services for metabolic disorders
Molecular imaging is becoming increasingly important particularly with regards to drug development. These non-invasive techniques bring mechanistic datas, through functional imaging, and efficacy assessment of compounds thanks to the use of follow-up markers.
These techniques are indispensible in making our preclinical studies more predictable and give more powerful translational tools for the clinical development.
Physiogenex has strengthen its services for preclinical studies in the field of metabolic disorders and cardiovascular complications.
- Radioactive tagging of molecules of interest (to allow observations of its movements within a cell)
- Biodistribution of orginal molecules : the ways in which molecules travel around the body and pharmakinetics (studies of how active molecules can change in the body)
- The evaluation of the efficiency of new therapeutic molecules with validated radiotracers
- Phenotypic studies (physical characteristics) and functional studies on small animal models using validated radiotracers.